New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
15:16 EDTALTR, VAR, TER, SYK, ZZ, SNDK, NE, NFLX, LRCX, JEC, CCI, AAPL, AMGN, WDCCompanies reporting After the Market Close on Wednesday, January 23
Notable companies reporting after the closing bell on Wednesday include Altera (ALTR), Amgem (AMGN), Apple (AAPL), Crown Castle International (CCI), Jacobs Engineering Group (JEC), Lam Research (LRCX), Netflix (NFLX), Noble (NE), SanDisk (SNDK), Sealy (ZZ), Stryker (SYK), Teradyne (TER), Varian Medical Systems (VAR), and Western Digital (WDC).
News For ALTR;AMGN;AAPL;CCI;JEC;LRCX;NFLX;NE;SNDK;ZZ;SYK;TER;VAR;WDC From The Last 14 Days
Check below for free stories on ALTR;AMGN;AAPL;CCI;JEC;LRCX;NFLX;NE;SNDK;ZZ;SYK;TER;VAR;WDC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
August 19, 2014
14:19 EDTAAPLCarl Icahn says increased Apple position over past year
Carl Icahn tweeted in regards to Apple, "All my chips still on the table and in fact increased position over past year." Icahn added that anyone who invested in Apple last year when he recommended the stock would be up 53% including dividends.
13:54 EDTAAPLCarney a contender to take over top communications job at Apple, Re/code says
Subscribe for More Information
12:40 EDTAAPLApple nears life high, levels to watch
Subscribe for More Information
12:27 EDTAAPLIcahn says 'very sizable' shareholder of Apple, has not sold share
Subscribe for More Information
11:57 EDTAAPLApple shares reach $100, up 84c or 1%
09:38 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA CELG VLO VZ FB HD
08:27 EDTNFLXNetflix international opportunity larger than most realize, says MKM Partners
Subscribe for More Information
07:46 EDTJECJacobs designs and builds iron sulfate plant for Huntsman pigments in Italy
Subscribe for More Information
07:46 EDTJECJacobs receives contract from Hong Kong SAR government
Subscribe for More Information
06:32 EDTAAPLMorgan Stanley recommends adding to Apple positions
Subscribe for More Information
05:11 EDTAMGNGamida Cell announces investment, option agreement with Novartis
Subscribe for More Information
August 18, 2014
17:25 EDTAMGNAmgen announces AMG 416 study met its primary and all secondary endpoints
Amgen announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism, SHPT, in patients with chronic kidney disease,CKD, receiving hemodialysis, met its primary and all secondary endpoints. "The results from this second Phase 3 study help to confirm that AMG 416 could become an important new treatment option for dialysis patients with secondary hyperparathyroidism," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen. "Despite the variety of options available for the treatment of this disease, an unmet need remains for an intravenous therapy that can be administered along with hemodialysis. We look forward to sharing results of a head-to-head study evaluating AMG 416 compared to cinacalcet next year."
16:00 EDTNFLX, AAPLOptions Update; August 18, 2014
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN DG TSLA GILD FB ABX WFC C
08:31 EDTVARVarian Medical board authorizes repurchase of 6M shares through 2015
Subscribe for More Information
08:30 EDTAAPLApple starts production of smartphones with sapphire screens, Guardian says
Subscribe for More Information
07:58 EDTNFLXNetflix volatility at low end of historic range
Subscribe for More Information
07:58 EDTAAPLApple December quarter EPS likely to beat by 10%+, says RBC Capital
Subscribe for More Information
06:42 EDTAAPLApple may call 5.5-inch iPhone '6L,' 9to5Mac reports
Apple may call its rumored 5.5-inch iPhone model the "6L," 9to5Mac reports, citing Asia-based rumor site Apple Daily. In this scenario, the 4.7-inch iPhone would be called the iPhone 6. Reference Link
05:23 EDTAAPLInvenSense downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded InvenSense (INVN) to Neutral citing valuation with shares near its $25 price target. Goldman also believes the near-term catalyst of share gains at Apple (AAPL) has passed. InvenSense closed Friday down 1c to $24.99.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use